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ABSTRACT During development of the cellular slime
mold Dictyostelium discoideum, cAMP induces chemotaxis and
expression of different classes of genes by means of interaction
with surface cAMP receptors. We describe a cAMP derivative,
8-p-chlqrophenylthioadenosine 3',5'-cyclic monophosphate (8-
CPT-cAMP), which inhibits cAMP-induced chemotaxis at low
concentrations but induces chemotaxis at supersaturating con-
centrations. This compound, moreover, selectively activates
expression of aggregative genes but not of p reptive
genes. 8-CPT-cAMP induces normal cGMP and cAMP accu-
mulation but in contrast to cAMP, which increases inositol
1,4,5-trisphosphate levels, 8-CPT-cAMP decreases inositol
1,4,5-trisphosphate levels. The derivative induces reduced
activation of guanine nucleotide regulatory proteins, which
may cause its defective activation of inositol 1,4,5-trisphos-
phate production. Our data suggest that disruption of inosi-
tolphospholipid signaling impairs chemotaxis and expression of
a subclass of cAMP-regulated genes.
In the social amoebae Dictyostelium discoideum, extracel-
lular cAMP functions as a hormone-like signal; it induces the
expression of several classes of genes and regulates morpho-
genetic movement by acting as a chemoattractant (see ref. 1).
cAMP signal processing is very similar to that of mammalian
hydrophilic hormones, such as adrenaline, vasopressin, ace-
tylcholine, luteinizing hormone, and many others; its effects
on chemotaxis and gene expression are mediated by surface
receptors (2-6), which belong to the ubiquitous class of
seven-trans-membrane receptors, interacting with guanine
nucleotide regulatory protein (G) proteins (7, 8). This inter-
action results in activation of target enzymes, such as ade-
nylate cyclase, guanylate cyclase, and phospholipase C (see
ref. 9). Similar to the adrenergic receptor, for example,
cAMP receptors are encoded by a family of different genes,
of which three members have been cloned (10). Also, the
Dictyostelium G proteins belong to a multigene family (11).
Elucidation of signal-transduction cascades involved in gene
regulation and chemotaxis is of crucial importance for our
general understanding of these processes. By using mutants
and molecular genetic approaches, considerable progress has
been made in understanding some of the functional relations
between cAMP receptors, G proteins, second-messengers
systems, and the ultimate responses that they control (7,
11-17). We describe here a modified cAMP receptor ligand,
8-p-chlorophenylthioadenosine 3',5'-cyclic monophosphate
(8-CPT-cAMP), which may be a powerful pharmacological
tool for dissecting cAMP transduction cascades. This cAMP
derivative selectively activates some second-messenger sys-
tems, a subpopulation ofG proteins, and a subpopulation of
cAMP-regulated genes.
MATERIALS AND METHODS
Materials. Luciferin and guanosine 5'-[y-thio]triphosphate
GTP[yS] were from Boehringer Mannheim. 8-CPT-cAMP
was supplied by B. Jastorff (University of Bremen, Bremen,
F.R.G.) or purchased from Boehringer Mannheim. 8-Bro-
moadenosine 3',5'-cyclic monophosphate (8-Br-cAMP),
6-chloropurineriboside 3',5'-cyclic monophosphate (6-Cl-
cPUMP), o-nitrophenyl 3-D-galactoside, Geneticin (G418),
and phenylmethylsulfonyl fluoride were obtained from
Sigma, [2,8-3H]cAMP, [a-32P~dATP, and cGMP RIA kits
were from Amersham, and GTP[y35S] was from New En-
gland Nuclear.
Dictyostelium Strains and Culture Conditions. D. discoi-
deum strain NC4 and mutant synag 7 (18) were grown on
glucose/peptone agar in association with Escherichia coli
281. Two transformed axenic (AX2) cell lines (D19-lacZ and
CP2-luciferase) were grown in HL5 medium (19) in the
presence of G418 at 10 ug/ml. D19-lacZ cells contain the
vector pA6PTlac.1, which bears a gene fusion of D19 pro-
moter and lacZ (20); CP2-luciferase cells contain the vector
PB10.act.15.BKH.LUC.BAM, which carries a fusion of the
firefly luciferase gene and CP2 promoter (21).
Growing cells were freed from nutrients by repeated wash-
ing with 10 mM Na/K phosphate, pH 6.5 [phosphate buffer
(PB)]. Aggregation competence was induced by incubating
cells on PB agar at 2.5 x 106 cells per cm2 for 16 hr at 6°C or
by stimulating cells for 4 hr with 30 nM cAMP pulses at 6-min
intervals.
Binding and Phosphodiesterase (PDE) Assays. The affinity
of 8-CPT-cAMP for cAMP-dependent protein kinase and its
apparent Km and Vm. for cAMP PDE were determined by
described methods (22, 23). The effects of cAMP, 8-Br-
cAMP, and 8-CPT-cAMP on GTP[y35S]-binding to mem-
branes of aggregation-competent cells were measured, as
described by Snaar-Jagalska et al. (24).
Abbreviations: G protein, guanine nucleotide regulatory protein;
PDE, cAMP phosphodiesterase; cAK, cAMP-dependent protein
kinase; cAR, cAMP receptor; csA, contact sites A; InsP3, inositol
1,4,5-trisphosphate; GTP[yS], guanosine 5'-[y-thio]triphosphate;
8-CPT-cAMP, 8-p-chlorophenylthioadenosine 3',5'-cyclic mono-
phosphate; 8-Br-cAMP, 8-bromoadenosine 3',5'-cyclic monophos-
phate; 6-Cl-cPUMP, 6-chloropurineriboside 3',5'-cyclic monophos-
phate; PB, phosphate buffer.
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Table 1. Binding characteristics of cAMP derivatives
K'd of surface cAMP-binding sites K'd of PDE
AH AL B C cAR K'm VI
cAMP (60*) (450*) (15*) (300t) (2.2t) (1000§)
Derivative
8-CPT-cAMP 280t 250t 230t 40t 0.24 2.9 0.7
8-Br-cAMP 220t 160t 130t 70t 0.32t 9.2§ 2.2§
6-Cl-cPUMP 2500* 2200* 1400* 1400t 2.21* 2.7§ 0.7§
Kd, Kd of derivative/Kd of cAMP; V', V..) of derivative/V,, of cAMP; K', Km of derivative/Km
of cAMP. Kd values (in nM) of cAMP binding to the different receptors are indicated in parentheses.
*Data are derived from ref. 35.
tData are derived from ref. 34.
*Data are derived from ref. 22.
§Data are derived from ref. 23.
Analysis of mRNA Levels, lacZ, and Luciferase Gene
Expression. Total cellular RNA was isolated from 2.5 x 107
cells, purified, size-fractionated on 1.5% agarose gels con-
taining 2.2 M formaldehyde, and transferred to nylon mem-
branes (25). RNA transfers were hybridized to 32P-labeled
cDNAs, according to standard procedures (26). f3-Galacto-
sidase activity in cell lines transformed with D19-lacZ con-
structs was measured essentially as described by Dinger-
mann et al. (20). To measure luciferase activity, cells were
lysed with 100 ,ul of lysis buffer A [8 mM MgCl2/1 mM
EDTA/1 mM dithiothreitol/1% Triton X-100/15% (vol/vol)
glycerol/0.5 mM phenylmethylsulfonyl fluoride in 100 mM
potassium phosphate, pH 7.5]. Subsequently 100 ,ul of 2%
bovine serum albumin in lysis buffer A was added to the
lysate. Reactions were started by adding 15 ,l of 0.86 mM
luciferin in 0.14 mM ATP to 25 ,ul of cell lysate (27).
Chemoluminescence was measured by using the single pho-
ton-counting facility of an LKB model 1218 liquid-
scintillation counter.
cGMP, cAMP, and Inositol 1,4,5-trisphosphate (InsP3) Re-
sponses. To measure cGMP responses, aliquots of 108 cells
per ml were stimulated with cAMP or 8-CPT-cAMP in the
presence of 2 mM dithiothreitol. After 0 or 10 s, incubation
was terminated by adding an equal volume of 3.5% (vol/vol)
perchloric acid, and cGMP levels were measured in neutral-
ized extracts by RIA.
cAMP responses were induced by stimulating 27-Al ali-
quots of 2 X 108 cells per ml at 0°C with 3 ,ul of cAMP or
8-CPT-cAMP in 5 mM dithiothreitol. After 0 or 4 min of
stimulation, 1.5 ml of ice-cold PB was added, cells were
centrifuged for 5 s at 10,000 x g, supernatant was removed,
and pellets were lysed in 30 ,ul of3.5% perchloric acid. cAMP
levels were measured by competition with [3H]cAMP for
binding to aggregation-competent D. discoideum cells, using
the ammonium sulfate stabilization assay (28).
To measure agonist-induced InsP3 accumulation, cells
were resuspended in 40 mM Hepes, pH 6.5, to 5 x i07 cells
per ml and stimulated with cAMP or 8-CPT-cAMP. At 4-s
intervals, 30-,ul aliquots were added to equal volumes of3.5%
perchloric acid. InsP3 levels were determined by isotope-
dilution assay (29).
RESULTS
Binding of 8-CPT-cAMP to cAMP Receptors and Induction
of Chemotaxis. Dictyostelium cells exhibit several kinetically
distinct classes of surface cAMP-binding sites (30, 31), an
intracellular cAMP-dependent protein kinase (cAK) (32) and
a cAMP-specific PDE (33). Surface-binding sites can be
distinguished as rapidly dissociating AH and AL sites, slowly
dissociating B sites (30, 31), and a putative third class-the
low-affinity C sites, which, in contrast to A and B sites, are
resistant to downregulation by cAMP (34). The relative
affinity of 8-CPT-cAMP, 8-Br-cAMP, and 6-Cl-cPUMP for
all these binding sites is summarized in Table 1. Both
8-CPT-cAMP and 8-Br-cAMP are good cAK agonists; these
agents bind to A and B sites with -200-fold lower affinity
than does cAMP and to C sites with -50-fold lower affinity.
Degradation by PDE is similar compared with cAMP. 6Cl-
cPUMP binds well to cAK but binds to all surface cAMP-
binding sites with >1000-fold lower affinity than does cAMP.
Chemotaxis of aggregative D. discoideum cells to 8-CPT-
cAMP and cAMP was compared by using the small popula-
tion assay (36). Fig. 1 shows that cAMP induces a half-
maximal chemotactic response at -3 nM, and 8-CPT-cAMP
induces the same level response at 50 ,uM. This concentration
is -80-fold higher than expected from the relative affinity of
8-CPT-cAMP for surface receptors. Most surprisingly, at
lower concentrations (0.1-10 uM), 8-CPT-cAMP antagonizes
chemotaxis induced by cAMP. Apparently, at low concen-
trations 8-CPT-cAMP acts as an antagonist of cAMP, and at
high concentrations it acts as an agonist.
Induction ofGene Expression by 8-CPT-cAMP. The expres-
sion of aggregative genes coding for cAMP receptors (cAR),
for example, and contact sites A (csA) can be effectively
induced by nanomolar cAMP pulses (7, 37-39). Fig. 2 shows
that in wild-type NC4 cells, 8-CPT-cAMP pulses are almost
as effective as cAMP pulses at inducing cAR and csA gene
expression. However, because 8-CPT-cAMP can induce
cAMP relay (see Fig. 6), this result may be due to 8-CPT-
cAMP-induced cAMP production. In mutant synag 7, which
is defective in adenylate cyclase activation (15, 18), induction
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FIG. 1. Induction of chemotaxis. Aggregation-competent NC-4
cells were deposited as 0.1-,ul droplets of 107 cells per ml on
hydrophobic agar. Droplets of the same volume of different concen-
trations ofcAMP (e), 8-CPT-cAMP (A), or a combination of 10-8 M
cAMP with different concentrations of 8-CPT-cAMP (-) were
placed close to the cell droplets. Each concentration was tested on
20 small populations. Every 15 min the number of droplets showing
a positive response was scored. Means and SEMs derived from four
experiments are presented.
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FIG. 2. Induction of aggregative gene expression. Vegetative
NC4 and synag (sng) 7 cells were incubated at 5 x 106 cells per ml
in PB and stimulated with the indicated concentrations of cAMP or
8-CPT-cAMP at 6-min intervals. mRNA was isolated after 3 hr of
incubation. Northern (RNA) blots were probed with csA and cAR1
cDNAs.
10- to 100-fold higher concentrations than induction by
cAMP. This dose dependency agrees with the relative affinity
of8-CPT-cAMP for surface cAMP-binding sites and indicates
that 8-CPT-cAMP is a full agonist for aggregative gene
expression.
Postaggregative genes are expressed in response to micro-
molar cAMP concentrations (4, 5). Fig. 3 shows the effect of
cAMP, 8-CPT-cAMP, 8-Br-cAMP, and 6-Cl-cPUMP on
expression of the prespore gene D19 (40) and the postaggre-
gative gene CP2, which is preferentially expressed in prestalk
cells (41). cAMP induces half-maximal expression of both
genes at -30 AM; expression is also induced by 1 mM of
6-Cl-cPUMP and 8-Br-cAMP, but no increase of D19 or CP2
mRNA levels was detectable at 8-CPT-cAMP concentrations
up to 1 mM.
Dose-response relationships measured during prolonged
incubation of cells with cAMP derivatives do not reflect true
affinities of the cAMP-binding proteins because considerable
degradation by PDE occurs during the incubation. Degrada-
tion of cAMP and cAMP derivatives by PDE can be reduced
by incubating cells at low cell density. With transformants
carrying promoter-reporter gene constructs, cell density
could be reduced 10- to 20-fold (Fig. 4). At low cell density,
half-maximal activation of the CP2 and D19 promoter is
FIG. 4. Effects of cAMP derivatives on D19 and CP2 promoter
activity. Aggregation-competent cells, transformed with D19-lacZ
constructs or CP2-luciferase constructs, were incubated as 100-.tl
aliquots of, respectively, 106 or 5 x 105 cells per ml in microtiter
plates and shaken intermittently on an Eppendorf shaker. cAMP (o),
8-CPT-cAMP (A), or6-Cl-cPUMP (-) were added at 60-min intervals.
P-Galactosidase (f3-Gal) and luciferase activities were measured after
6 hr of incubation. Data are expressed as percentage of values
obtained after incubation with 10-5 M cAMP; means and SEMs of
three experiments done in quadruplicate are presented.
induced by 2 u.M cAMP or 50 ,uM 6-Cl-cPUMP, whereas
8-CPT-cAMP induces very low levels of expression at 1 mM.
Activation of Second Messengers by 8-CPT-cAMP. Stimu-
lation of cells with cAMP induces transient accumulation of
the intracellular messengers cGMP, cAMP, and InsP3, which
peak at, respectively, 10 s, 3 min, and 5 s. Fig. 5 shows
dose-response relationships of cGMP accumulation induced
by cAMP and 8-CPT-cAMP, measured 10 s after stimulation.
About 50 times higher concentrations of 8-CPT-cAMP than
cAMP are required to induce a half-maximal cGMP response.
Induction of cAMP accumulation by 8-CPT-cAMP and
cAMP was also determined. 8-CPT-cAMP has a high affinity
for bovine cAK, which is generally used in the isotope
dilution assay to measure cAMP accumulation. To prevent
interference of the stimulus, cells were stimulated at 0°C, a
temperature at which cAMP synthesis is normal, but cAMP
secretion is strongly retarded (42). Cells could then be
washed to remove 8-CPT-cAMP, and accumulated cAMP
levels were determined by competition with [3HJcAMP for
binding to surface cAMP-binding sites, which have a rela-
tively low affinity for 8-CPT-cAMP (Table 1). The cAMP
relay inhibitor caffeine (43) was used as a control to show that
the 8-CPT-cAMP stimulus does not contribute to measured
cAMP levels. Fig. 6 shows that 8-CPT-cAMP can induce
cAMP synthesis to the same levels as cAMP and, therefore,
also acts as an agonist on this second-messenger system.
Fig. 7 shows effects of cAMP and 8-CPT-cAMP on InsP3
accumulation. Dictyostelium cells have rather high basal
InsP3 levels (44), which show a small but significant increase
after cAMP stimulation. Stimulation with 8-CPT-cAMP does











FIG. 3. Induction of prespore and prestalk gene
expression. Aggregation-competent cells were resus-
D19 pended to 107 cells per ml in PB and stimulated with the
indicated concentrations of cAMP, 8-Br-cAMP, 6-Cl-
cPUMP, or 8-CPT-cAMP at 60-min intervals. mRNA was
isolated after 3 or 5 hr of incubation, and Northern blots
were probed with, respectively, CP2 and D19 cDNAs. The
low-intensity D19 mRNA band at 3 x 10-5 M 8-CPT-
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Fio. 5. Induction of cGMP accumulation. Aggregation-
competent NC-4 cells were stimulated with the indicated concen-
trations of cAMP (e) or 8-CPT-cAMP (A) in the presence of 2 mM
dithiothreitol. After 10 s, incubation was terminated, and cGMP
levels were measured. Data are presented as percentage of cGMP
levels obtained after stimulation with 10-3 M 8-CPT-cAMP. Means
and SEMs of three experiments done in triplicate are presented.
derivative activates an inhibitory, rather than a stimulatory,
pathway.
Activation of phospholipase C is mediated by at least one
G protein. We measured whether 8-CPT-cAMP can increase
GTP[yS] binding to membranes, which characterizes activa-
tion of G proteins (24, 45). Fig. 8 shows that cAMP induces
a >2-fold increase of GTP[yS] binding. Half-maximal induc-
tion is achieved by 100 nM. 8-Br-cAMP induces the same
increase as cAMP at 50-fold higher concentrations. 8-CPT-
cAMP starts to increase GTP[yS] binding at the same con-
centrations as 8-Br-cAMP, but even at saturating concenltra-
tions, the 8-CPT-cAMP-induced increase is only half that
induced by cAMP and 8-Br-cAMP. Apparently 8-CPT-cAMP
cannot activate a subpopulation of G proteins.
DISCUSSION
We describe a cAMP derivative, 8-CPT-cAMP, which inhib-
its cAMP-induced chemotaxis at low concentrations, while
inducing chemotaxis at supersaturating concentrations.
8-CPT-cAMP induces virtually normal accumulation of the
second-messengers cAMP and cGMP but is defective in
inositol phospholipid signaling and induces a decrease, rather
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FIG. 7. Induction ofInsP3 accumulation. Vegetative cells starved
for 4 hr in PB were resuspended in 40 mM Hepes, pH 6.5. Three
batches of cells were simultaneously stimulated either with 10-6 M
cAMP (e), 10-4M 8-CPT-cAMP (v), or with water. At the indicated
time intervals, aliquots were transferred to perchloric acid, and InsP3
levels were measured. Data are expressed as percentage of basal
level (stimulation with water). Means and SEMs ofthree experiments
done in triplicate are presented. **, Data are significant below basal
level; *, data are significant above basal level (Student's t test, P <
0.05).
can be explained by putative control of phospholipase C by
both a stimulatory and an inhibitory G protein, with 8-CPT-
cAMP only activating the inhibitory G protein. Compared
with cAMP and 8-Br-cAMP, 8-CPT-cAMP shows a strongly
reduced ability to increase the binding ofGTP[yS] to Dictyo-
stelium membranes (Fig. 8). This result indicates that 8-CPT-
cAMP cannot activate a subpopulation of G proteins, pre-
sumably those responsible for phospholipase C activation.
The aberrant 8-CPT-cAMP-induced InsP3 response may
explain its behavior as a partial chemotactic antagonist.
Studies using chemotactic mutants and introduction of sec-
ond messengers into permeabilized cells have suggested that
cGMP and InsP3 signaling may respectively control myosin
and actin polymerization (12, 17, 47, 48); 8-CPT-cAMP may
antagonize chemotaxis by counteracting the cAMP-induced
increase of InsP3 levels. However, because 8-CPT-cAMP
induces a normal cGMP response, this may, at saturating
concentrations, suffice to induce some chemotaxis, perhaps
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FIG. 6. Induction of cAMP accumulation. Competent NC4 cells
were stimulated at 00C with the indicated concentrations ofcAMP or
8-CPT-cAMP (8CPT) in 5 mM dithiothreitol in the absence (light
bars) or presence (dark bars) of 5 mM caffeine. After 4 min,
incubation was terminated, and cAMP levels were measured. Means
and SEMs of three experiments are shown.
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FIG. 8. Activation of GTP[yS] binding. Equilibrium binding of
GTP[y"5S] to membranes from aggregation-competent cells was
measured in the presence of cAMP (-), 8-Br-cAMP (*), or 8-CPT-
cAMP (A). Data are expressed as percentage of GTP[IyS] binding in
the absence of cyclic nucleotides (7000 cpm per 107 cells). Means and
SEMs of three experiments are presented.
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The observation that 8-CPT-cAMP induces accumulation
of cGMP but not of InsP3 contradicts an earlier hypothesis
that guanylate cyclase is activated by means of the InsP3/
Ca2+ pathway (49, 50). Remarkably, the cGMP response
induced by 8-CPT-cAMP reaches much higher levels than
that induced by cAMP (Fig. 5), which suggests that the
cAMP-induced InsP3 response may have a negative effect on
cGMP accumulation. This hypothesis is supported by obser-
vations that both InsP3 and Ca2+ strongly inhibit guanylate
cyclase activity in vitro (51).
The ambiguous behavior of8-CPT-cAMP on chemotaxis is
also reflected in its effects on gene expression. 8-CPT-cAMP
induces normal aggregative gene expression (Fig. 2) but is
virtually ineffective in inducing postaggregative gene expres-
sion. cAMP-induced gene expression may be mediated by
cAMP, cGMP, InsP3/Ca2+, or yet-unknown cAMP-induced
responses. Earlier studies made involvement of cAMP in
gene regulation unlikely because both aggregative and post-
aggregative gene expression occur under conditions that
prevent adenylate cyclase activation (5, 15, 16). FgdA mu-
tants that are defective in the G protein, G2, mediating
phospholipase C activation (11, 13, 14), show no cAMP-
induced expression of aggregative genes (16, 52) and no
cAMP or cGMP responses (14, 53). It was suggested that
G2-mediated inositolphospholipid signaling mediates all
cAMP-induced responses, including aggregative gene
expression (11, 14, 53). The observation that 8-CPT-cAMP
reduces InsP3 levels but induces normal aggregative gene
expression, as well as cAMP and cGMP accumulation,
contradicts this suggestion. The defective G protein is pos-
sibly linked to other target proteins or could be required for
an event early in development, which is required for subse-
quent differentiation.
Several data implicate InsP3 in induction of prespore gene
expression. Prespore gene expression cannot be induced by
8-CPT-cAMP, is effectively inhibited by Ca2+ antagonists
(15, 54) and by LiCI which inhibits cAMP-induced InsP3
accumulation (44), and can be induced under special condi-
tions by InsP3/diacylglycerol pulses (46). Expression of
prestalk-related genes, such as CP2, is probably not mediated
by InsP3/Ca2+ because this response is not inhibited by Ca2+
antagonists (54) or lithium (44) and is counteracted by InsP3/
diacylglycerol pulses (46). Why 8-CPT-cAMP cannot induce
CP2 gene expression is unclear. This response may be
mediated by presently unknown intracellular messenger sys-
tems, which cannot be activated by 8-CPT-cAMP. The
effects of 8-CPT-cAMP and lithium on the cGMP response
correlate well with effects on aggregative gene expression.
Both responses are effectively induced by 8-CPT-cAMP and
stimulated by lithium (unpublished work), which suggest that
cGMP may mediate induction of aggregative gene expres-
sion.
The present study shows that 8-CPT-cAMP is a very useful
tool to unravel involvement of specific cAMP signal-
transduction pathways in the great variety of cAMP-induced
responses.
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